|
Market Closed -
Oslo Bors
17:45:00 25/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 43.80 NOK | -2.23% |
|
+0.23% | -4.99% |
| 09-23 | DNB Carnegie raises OMDA price target to 66 Norwegian kroner (61), reiterates buy | FW |
| 09-23 | Omda Completes Rollout of Oncology Medication Software in Norway | MT |
Company Valuation: Omda
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,803 | 796.8 | 755.7 | 665 | 945.4 | 898.2 | - | - |
| Change | - | -55.81% | -5.16% | -11.99% | 42.16% | -4.99% | - | - |
| Enterprise Value (EV) 1 | 2,014 | 1,095 | 1,112 | 1,026 | 1,350 | 1,304 | 1,224 | 1,116 |
| Change | - | -45.64% | 1.58% | -7.7% | 31.58% | -3.42% | -6.13% | -8.82% |
| P/E | -20.2x | -6.05x | 7.43x | -11.7x | 149x | -42.9x | 16.9x | 11.9x |
| PBR | 10.8x | 27.7x | 8.14x | 40.6x | 59x | 274x | 15.9x | 6.81x |
| PEG | - | -0.1x | -0x | 0x | -1x | 0x | -0x | 0.3x |
| Capitalization / Revenue | 5.45x | 2.16x | 1.82x | 1.55x | 1.91x | 1.78x | 1.36x | 1.3x |
| EV / Revenue | 6.09x | 2.96x | 2.68x | 2.39x | 2.72x | 2.58x | 1.85x | 1.61x |
| EV / EBITDA | 48.1x | 474x | 17.6x | 19.4x | 11.6x | 9.32x | 6.55x | 5.1x |
| EV / EBIT | -50.9x | -12.1x | 8.64x | -327x | 26.9x | 17.4x | 10.6x | 7.65x |
| EV / FCF | -736x | -21.6x | -412x | 15.9x | 41.3x | 38.4x | 10.8x | 10.2x |
| FCF Yield | -0.14% | -4.62% | -0.24% | 6.28% | 2.42% | 2.61% | 9.23% | 9.76% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -4.251 | -6.276 | 4.977 | -2.828 | 0.3099 | -1.02 | 2.59 | 3.68 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 330.7 | 369.7 | 415.1 | 429 | 495.7 | 505 | 660 | 693 |
| EBITDA 1 | 41.83 | 2.307 | 63.26 | 52.94 | 116.7 | 140 | 187 | 219 |
| EBIT 1 | -39.54 | -90.45 | 128.7 | -3.137 | 50.18 | 75 | 116 | 146 |
| Net income 1 | -89.12 | -131.6 | 104.4 | -59.29 | 6.608 | -22 | 55 | 78 |
| Net Debt 1 | 210.5 | 297.9 | 356.3 | 361.3 | 405.1 | 406 | 326 | 218 |
| Reference price 2 | 86.00 | 38.00 | 37.00 | 33.00 | 46.10 | 43.80 | 43.80 | 43.80 |
| Nbr of stocks (in thousands) | 20,967 | 20,967 | 20,423 | 20,153 | 20,508 | 20,508 | - | - |
| Announcement Date | 2/25/22 A | 2/28/23 A | 3/1/24 A | 2/26/25 A | 3/2/26 A | - | - | - |
1NOK in Million2NOK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -42.94x | 2.58x | 9.32x | - | 94.58M | |
| 42.97x | 10.4x | 22.93x | -.--% | 45.44B | |
| 89.81x | 48.8x | 61.96x | 0.59% | 11.81B | |
| 73.6x | 12.79x | 50.3x | 0.7% | 5.54B | |
| -65.14x | 16.54x | -108.31x | - | 4.28B | |
| -6.5x | 57.52x | -6.52x | - | 1.94B | |
| 34.23x | - | - | -.--% | 1.54B | |
| -119.08x | - | - | - | 1.01B | |
| 6.68x | - | - | - | 960M | |
| Average | 1.52x | 24.77x | 4.94x | 0.32% | 8.07B | |
| Weighted average by Cap. | 42.21x | 18.85x | 22.83x | 0.17% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CSAM Stock
- Valuation Omda
Select your edition
All financial news and data tailored to specific country editions
